Ascorbic acid (vitamin C) exerts an antioxidant action not only by itself but also by interacting with reduced glutathione (GSH) or vitamin E (1, 2) . It is known that ascorbic acid scavenges reactive oxygen species (ROS) generated in activated neutrophils and in the hyoxanthine-xanthine oxidase (XO) system and hypochlorous acid derived from myeloperoxidase present in neutrophils in vitro (3) (4) (5) .
Ekman et al. (6, 7) have reported that a single intraarterial pretreatment with ascorbic acid reduces gastric bleeding after hemorrhagic shock and retransfu sion in rats and that the same ascorbic acid pretreat ment prevents gastric mucosal energy depletion after hemorrhagic shock and gastric mucosal vessel injury after retransfusion in rats. Alptekin et al. (8) have shown in rats exposed to water immersion restraint stress for 2.5h that pre-administration of ascorbic acid in drinking water for 15d reduces microscopically observed gastric mucosal injury, although neither the ascorbic acid pre-administration nor 2.5h of water immersion restraint stress causes any change in ascor bic acid, GSH, and lipid peroxide levels in the gastric mucosal tissue. Thus, administered ascorbic acid pro tects against acute gastric mucosal lesions induced by hemorrhagic shock and retransfusion or stress. How ever, it is still unknown whether gastric mucosal ascor bic acid status changes with the development of experimentally induced acute gastric mucosal lesions.
Compound 48/80 is known to cause degranulation of connective tissue mast cells, but not mucosal mast cells, with release of serotonin and histamine from the cells (9, 10) . We have shown in rats with a single com pound 48/80 treatment that gastric mucosal lesions develop with decreases in Se-glutathione peroxidase activity and vitamin E content and increases in neutro phil infiltration, XO activity, and lipid peroxide level in the gastric mucosal tissue and that gastric mucosal blood flow is reduced with gastric mucosal lesion forma-E-mail: yohta@fujita-hu.ac.jp tion, while the decreased blood flow is recovered with the lesion progression and recovery (11). We have also shown in rats treated once with compound 48/80 that neutrophils infiltrating into the gastric mucosal tissue participate in gastric mucosal lesion formation and pro gression, while the xanthine-XO system in the gastric mucosal tissue takes part mainly in the lesion progres sion (12) . These findings may allow us to assume that gastric mucosal ascorbic acid status may change during the development of compound 48/80-induced acute gastric mucosal lesions in rats.
In the present study, therefore, we examined the changes in the gastric mucosal levels of total, reduced, and oxidized ascorbic acids with the formation, progres sion, and recovery of acute gastric mucosal lesions in rats treated once with compound 48/80. Ascorbic acid can be synthesized in the liver of rats (13) . Hepatocytes have the capacity to release ascorbic acid in its reduced form (14) . It is known that a single administration of compound 48/80 to rats affects the intrahepatic microvascular regulatory mechanisms by releasing mast cell constituents, such as serotonin and hista mine, following mast cell degranualtion induced by the administered compound (15) . Accordingly, the changes in the serum and hepatic levels of total, reduced, and oxidized ascorbic acids with the formation, progression, and recovery of compound 48/80-induced acute gastric mucosal lesions were examined in order to clarify whether the change in systemic ascorbic acid status is related with the changes in gastric mucosal ascorbic acid status in the compound 48/80-treated rats. Induction and observation of gastric mucosal lesions. Rats (7wk old) fasted for 24h received a single intra peritoneal (i.p) injection of compound 48/80 (0.75mg/ kg body weight), dissolved in distilled water, as described previously (11, 12) . The control rats received an i.p, injection of an equal volume of distilled water. All animals were maintained with free access to water and without food during the experiment. The animals were sacrificed under ether anesthesia 0. We have shown in rats treated once with compound 48/80 that gastric mucosal Se-glutathione peroxidase activity and vitamin E level decrease with the progres sion of gastric mucosal lesions, while gastric mucosal neutrophil infiltration, XO activity, and lipid peroxide level increase with the formation and progression of the lesions and all these changes found at a progressed stage of the lesions are attenuated at a recovery stage of the lesions (11). Se-glutathione peroxidase decomposes both hydrogen peroxide and lipid hydroperoxides (18) . Vitamin E functions as a chain-breaking antioxidant for lipid peroxidation in cell membranes and also as a scav enger of ROS (19) . The xanthine-XO system and acti vated NADPH oxidoreductase in neutrophils generate ROS such as superoxide radical and hydrogen peroxide (20, 21) . It is known that lipid peroxidation occurs via ROS generated not only by the xanthine-XO system but also by activated NADPH oxidoreductase in neutrophils (22, 23) . It is also known that myeloperoxidase present in neutrophils mediates lipid peroxidation in the pres-ence of hydrogen peroxide and halide ions (24). Reduced ascorbic acid not only scavenges ROS and hypochlorous acid but also supports the chain-breaking antioxidant action of vitamin E by reduction of vitamin E radical to vitamin E at the lipid/aqueous interface (1 5). These findings suggest that the loss of reduced ascor bic acid with lesion progression found in the gastric mucosa of rats treated once with compound 48/80 could be associated with the antioxidant action of the vitamin to scavenge ROS and hypochlorous acid gener ated by infiltrated neutrophils and ROS generated by the xanthine-XO system and to recycle vitamin E in the gas tric mucosal tissue. jejunum, ileum, and colon tissues of rats (30) . There fore, a possibility cannot be ruled out that a decrease in the activity of an enzyme to reduce oxidized ascorbic acid contributes to the loss of reduced ascorbic acid in the gastric mucosal tissue of rats treated once with compound 48/80. Ascorbic acid can be synthesized in the liver of rats (13) . Hepatocytes releases ascorbic acid in its reduced form (14) . It is known that a single administration of compound 48/80 to rats affects the intrahepatic microvascular regulatory mechanisms (15) . Therefore, we further examined whether a change in systemic ascorbic acid status contributes to the disruption of gas tric mucosal ascorbic acid status with gastric mucosal lesion progression in rats treated once with compound 48/80. The serum concentrations of total and reduced ascorbic acids in compound 48/80-treated rats increased significantly with the formation of gastric mucosal lesions and further increased with the progres sion of the lesions but the increased concentrations of In the present study, the gastric mucosal concentra tion of oxidized ascorbic acid did not change at a pro gressed stage of acute gastric mucosal lesions in compound 48/80-treated rats despite a marked decrease in the gastric mucosal concentration of reduced ascorbic acid. It is known that oxidized ascorbic acid is rapidly degraded to 2,3-diketogulonic acid in animal tissues if not converted back to reduced ascorbic acid by enzy matic and/or non-enzymatic recycling, since oxidized ascorbic acid is unstable at physiological pH (31) . From this finding, it is assumed that oxidized ascorbic acid formed upon the oxidation of reduced ascorbic acid is rapidly degraded to 2,3-dilketogulonic acid without its conversion back to reduced ascorbic acid in the gastric mucosal tissue of rats treated once with compound 48/ 80, resulting in no increase in the gastric mucosal con centration of oxidized ascorbic acid. 
